Pharma Manufacturer Federal Government Price Reporting: Recent Litigation and Settlements
Litigation involving drug price reporting under the Medicaid Drug Rebate Program (MDRP) has been very active in 2022.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year